UPDATE : Tuesday, June 18, 2019
‘Korean drugmakers can tap US generic market’ by Jeong Sae-im 2019-03-07 11:54
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate by Lee Han-soo 2019-03-06 14:27
Binex, Chongqing Zein to establish joint company by Lee Han-soo 2019-03-06 13:41
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin by Lee Han-soo 2019-03-05 16:22
Hanmi’s acute myeloid leukemia wins developmental stage orphan drug status by Lee Han-soo 2019-03-05 15:34
Handok to market Amicus Therapeutics’ Fabry disease treatment by Lee Han-soo 2019-03-05 15:11
Lilly Korea to test rheumatoid arthritis drug for hair loss treatment by Lee Hye-seon 2019-03-05 15:10
3rd-generation antiepileptic drug lands on Korea by Lee Hye-seon 2019-03-05 14:42
IVI gets $3.2 million for typhoid conjugate vaccine study in W. Africa by Lee Han-soo 2019-03-05 14:41
Hanmi releases P4 clinical trials for anti-hypertension treatment by Lee Han-soo 2019-03-04 17:01
Regulator expands XGEVA’s indication for use by multiple myeloma patients by Kim Yun-mi 2019-03-04 16:02
AbbVie gets positive views for treatment of plaque psoriasis in EU by Lee Han-soo 2019-03-04 15:57
Qurient unveils P2a trial results for atopic dermatitis treatment in US by Lee Han-soo 2019-03-04 14:16
US trade agency begins probe into Medytox’s complaint about Daewoong by Lee Han-soo 2019-03-04 11:16
GC starts P1 trials of hemophilia treatment by Lee Han-soo 2019-02-28 16:45
Bukwang to sell Novartis’ chronic hepatitis B treatment by Lee Han-soo 2019-02-28 14:59
Chong Kun Dang topped clinical trials in 2018 by Lee Hye-seon 2019-02-28 10:50
Korea’s 30th novel drug K-Cab to get insurance benefit from March by Lee Hye-seon 2019-02-27 16:47
Korea’s drug exports hit record high in 2018, industry group says by Kim Yun-mi 2019-02-27 13:08
GC unveils P1 results for hepatitis B treatment by Lee Han-soo 2019-02-26 16:07
Back to Top